Riverhead Capital Management’s Lannett Company, Inc. LCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$122K Hold
2,725
﹤0.01% 1282
2019
Q2
$66K Buy
+2,725
New +$72K ﹤0.01% 1415
2018
Q3
Sell
-997
Closed -$54K 1584
2018
Q2
$54K Hold
997
﹤0.01% 1453
2018
Q1
$64K Buy
997
+50
+5% +$3.85K ﹤0.01% 1432
2017
Q4
$88K Buy
947
+100
+12% +$9.75K ﹤0.01% 1379
2017
Q3
$62K Buy
847
+181
+27% +$13.3K ﹤0.01% 1410
2017
Q2
$54K Buy
666
+341
+105% +$29.7K ﹤0.01% 1400
2017
Q1
$29K Buy
325
+25
+8% +$2.14K ﹤0.01% 1410
2016
Q4
$26K Hold
300
﹤0.01% 1391
2016
Q3
$32K Sell
300
-393
-57% -$48K ﹤0.01% 1303
2016
Q2
$354K Sell
693
-395
-36% -$33.8K 0.01% 694
2016
Q1
$78K Sell
1,088
-362
-25% -$38.3K ﹤0.01% 1351
2015
Q4
$233K Buy
1,450
+1,000
+222% +$164K ﹤0.01% 1224
2015
Q3
$75K Buy
+450
New +$98.8K ﹤0.01% 1179

Other funds holding LCI

Riverhead Capital Management's LCI Position: Q3 2019 in Review

Riverhead Capital Management held its Lannett Company, Inc. (LCI) position steady in Q3 2019 at 2,725 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

Riverhead Capital Management first reported a position in LCI in Q3 2015 and has held it in 14 quarters since. The position peaked at $354K in Q2 2016. 167 funds tracked by Wall St. Rank hold LCI as of Q3 2019.

  • Riverhead Capital Management held 2,725 shares of Lannett Company, Inc. worth $122K as of Q3 2019.
  • Riverhead Capital Management left its Lannett Company, Inc. share count unchanged in Q3 2019.
  • Lannett Company, Inc. made up ﹤0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1282 holding.
  • Riverhead Capital Management first reported a position in Lannett Company, Inc. in Q3 2015 and has held it in 14 quarters since.
  • Riverhead Capital Management's Lannett Company, Inc. position peaked at $354K in Q2 2016.
  • 167 funds tracked by Wall St. Rank held Lannett Company, Inc. as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.